Immunomedics, Inc. (NASDAQ:IMMU) Investor Alert: Lawsuit Alleges False and Misleading Statements
An investor, who purchased shares of Immunomedics, Inc. (NASDAQ:IMMU), filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Immunomedics, Inc. in connection with certain allegedly false and misleading statements made between May 9, 2013 and October 9, 2013.
View full press release